Table 2 Examples of predicted breakpoints in breast tumor aCGH case study. Listing of Unigene IDs corresponding to predicted breakpoints for ChARMView results pictured in Figures 6A and 6B. The Unigene ID and gene name are the first and last markers included in the predicted amplification. All results listed have Bonferroni-corrected less than p-values of .05 for both mean and sign significance tests.
From: Visualization-based discovery and analysis of genomic aberrations in microarray data
Tumor sample | Chrom. | Predicted start breakpoint | Adjacent gene (in amplicon) | Predicted end breakpoint | Adjacent gene (in amplicon) |
|---|---|---|---|---|---|
110B | 1 | Hs.15871 | ACP6 | Hs.7395 (last marker) | TFB2M |
112B | 1 | Hs.59889 | HMGCS2 | Hs.7395 (last marker) | TFB2M |
122A | 1 | Hs.381235 | SEC22L1 | Hs.7395 (last marker) | TFB2M |
123B | 17 | Hs.97477 | LYZL6 | Hs.276916 | NR1D1 |
309A | 17 | Hs.73817 | CCL18 | Hs.267871 | PTRF1 |
BC-A | 17 | Hs.635 | CACNB1 | Hs.2340 | HAP1 |